Are GLPG insiders buying or selling?

In the last 90 days, Galapagos N.V. (GLPG) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own GLPG?

See every hedge fund and asset manager holding Galapagos N.V. (GLPG).

How much of GLPG trades in dark pools?

0.203M GLPG shares ($6M notional) traded off-exchange last week — block trades typical of institutional flow.

Galapagos N.V. (GLPG) Smart Money — Insiders, Congress, Hedge Funds

Also trades as: GLPG.BR (BRU)

$27.98

Last traded 2026-06-04 — delisted

NASDAQ · Healthcare · Biotechnology · $1.8B mcap · 45M float · 0.344% daily turnover · Short 67% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Smart Money Score

Watch 25

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$1.8B

52W Range24.74-37.78

Volume2,385

Avg Volume153,204

Beta0.30

Dividend—

Analyst Ratings

9 Buy 11 Hold 4 Sell

Consensus Hold

Company Info

CEOHenry O. Gosebruch

Employees452

SectorHealthcare

IndustryBiotechnology

IPO Date2012-02-27

Websitelakefrontbio.com

Generaal De Wittelaan L11 A3
Mechelen 2800
BE

32 1 534 29 00

About Galapagos N.V.

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Latest News